Valuation: RaySearch Laboratories AB

Market Cap 594.02Cr 60Cr 54Cr 49Cr 45Cr 85Cr 5.65TCr 87Cr 236.87Cr 3.02TCr 225.67Cr 220.83Cr 9.52TCr P/E 2026 *
22.9x
P/E 2027 * 17.9x
Enterprise Value 610.62Cr 62Cr 55Cr 51Cr 46Cr 87Cr 5.81TCr 90Cr 243.49Cr 3.1TCr 231.98Cr 227Cr 9.79TCr EV / Sales 2026 *
4.34x
EV / Sales 2027 * 3.7x
Free-Float
80.09%
Yield 2026 *
2.26%
Yield 2027 * 2.55%
1 day+1.03%
1 week-12.87%
Current month-12.87%
1 month-3.86%
3 months+0.11%
6 months-8.02%
Current year-22.50%
1 week 161.6
Extreme 161.6
203.4
1 month 161.6
Extreme 161.6
203.8
Current year 153.1
Extreme 153.1
238.4
1 year 153.1
Extreme 153.1
258.5
3 years 84.1
Extreme 84.1
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Date Insider Type Main position Quantity % Market Cap. Importance
18/08/26 Sell

Chief Technology Officer

-3,203 0.0104%
17/08/26 Sell

Chief Technology Officer

-2,297 0.0075%
11/06/26 Buy

General Counsel

462 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.03%-12.87%-16.06%+99.89% 60Cr
+2.63%-0.32%+22.75%+52.69% 25TCr
-3.36%+4.81%-17.34%+63.31% 16TCr
+1.73%-0.85%+9.29%+17.76% 16TCr
-4.23%+1.83%-56.84%-19.05% 6.47TCr
+1.31%+11.01%+23.90%+52.22% 5.8TCr
-0.76%+4.13%+0.84%-6.12% 5.62TCr
-2.05%-2.95%+4.30%+54.85% 5.02TCr
+1.73%-0.06%+18.49%+62.52% 4.84TCr
+1.00%-1.11%+23.29%+81.48% 4.45TCr
Average -0.10%-0.06%+1.26%+45.96% 8.95TCr
Weighted average by Cap. +0.20%+1.28%+4.76%+41.61%

Financials

2026 *2027 *
Net sales 140.7Cr 14Cr 13Cr 12Cr 11Cr 20Cr 1.34TCr 21Cr 56Cr 714.28Cr 53Cr 52Cr 2.25TCr 161.45Cr 16Cr 15Cr 13Cr 12Cr 23Cr 1.54TCr 24Cr 64Cr 819.62Cr 61Cr 60Cr 2.59TCr
Net income 26Cr 2.61Cr 2.34Cr 2.14Cr 1.95Cr 3.68Cr 245.47Cr 3.8Cr 10Cr 130.98Cr 9.8Cr 9.59Cr 413.48Cr 33Cr 3.32Cr 2.98Cr 2.72Cr 2.48Cr 4.68Cr 312.07Cr 4.83Cr 13Cr 166.51Cr 12Cr 12Cr 525.67Cr
Net Debt 17Cr 1.68Cr 1.51Cr 1.38Cr 1.26Cr 2.37Cr 157.94Cr 2.44Cr 6.62Cr 84Cr 6.31Cr 6.17Cr 266.04Cr 3.3Cr 33.4L 29.96L 27.38L 24.99L 47.09L 31Cr 48.57L 1.32Cr 17Cr 1.25Cr 1.23Cr 53Cr
Projected Income Statement - Annual - RaySearch Laboratories AB
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
06/26/06 SEK 176.70 +1.03% 1,19,241
05/26/05 SEK 174.90 +0.81% 1,86,222
04/26/04 SEK 173.50 +4.08% 4,04,408
03/26/03 SEK 166.70 -15.38% 13,56,311
02/26/02 SEK 197.00 -2.86% 1,55,961
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - RaySearch Laboratories AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
176.70SEK
Average target price
285.00SEK
Spread / Average Target
+61.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - RaySearch Laboratories AB
  1. Stock Market
  2. Stocks
  3. RAY B Stock